Susceptibility- and T2*-weighted MRI features of CNS large B-cell lymphoma in a large single-center cohort: prevalence, patterns, and clinical associations - Top-Institutions - MDSpire

Susceptibility- and T2*-weighted MRI features of CNS large B-cell lymphoma in a large single-center cohort: prevalence, patterns, and clinical associations

  • By

  • Christophe T. Arendt

  • Marie Löhlau

  • Linda Röder

  • Michael C. Burger

  • Elke Hattingen

  • Stefan Weidauer

  • July 12, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neuroradiology
    • Hematologic Oncology
    • Neuropathology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neuroradiology
    • Hematology
    • Neuropathology

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neuroradiology
    • Oncology
    • Neuropathology

  • #4

    University of Heidelberg
    University of Heidelberg

    Heidelberg, Baden-Württemberg

    Key Differentiators

    • Neuroradiology
    • Hematology
    • Neuropathology

  • #5

    Goethe University Frankfurt
    Goethe University Frankfurt

    Frankfurt, Hessen

    Key Differentiators

    • Neuroradiology
    • Hematology
    • Neuropathology

Original Source(s)

Susceptibility- and T2*-weighted MRI features of CNS large B-cell lymphoma in a large single-center cohort: prevalence, patterns, and clinical associations

  • by Christophe T. Arendt, Marie Löhlau, Linda Röder, Michael C. Burger, Elke Hattingen, Stefan Weidauer

  • July 12, 2025

Related Content

Barriers to Molecular Research in Gliomas: Implications for Precision Medicine in Resource-Limited Nations

A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validation

A pharmacodynamic study of rapid lactate metabolic modulation by intravenous L-arginine in brain metastases